Invesco Biotechnology & Genome ETF
PBE
#2117
ETF Rang
€0.21 Mrd.
Marktkapitalisierung
🇺🇸 US
Markt
67,55 €
Aktienkurs
1.04%
Veränderung (1 Tag)
28.82%
Veränderung (1 Jahr)
Kategorien

Invesco Biotechnology & Genome ETF - Bestände

ETF-Bestände zum Stand 9. April 2026Anzahl der Bestände: 32

Vollständige Bestandsliste

Gewichtung %NameTickerGehaltene Aktien
6.27%
United Therapeutics CorpUTHR27212
5.19%
Illumina IncILMN104832
5.13%
Regeneron Pharmaceuticals IncREGN16684
4.98%
Alnylam Pharmaceuticals IncALNY38706
4.97%
Gilead Sciences IncGILD87264
4.95%
Incyte CorpINCY127499
4.79%
Amgen IncAMGN33651
4.69%
Biogen IncBIIB66025
3.66%
BioCryst Pharmaceuticals IncBCRX923458
3.35%
Protagonist Therapeutics IncPTGX80415
3.20%
TG Therapeutics IncTGTX230335
3.00%
Royalty Pharma PLCRPRX154791
2.98%
Catalyst Pharmaceuticals IncCPRX290513
2.93%
Arrowhead Pharmaceuticals IncARWR110374
2.89%
PTC Therapeutics IncPTCT101877
2.83%
Exelixis IncEXEL155682
2.83%
Neurocrine Biosciences IncNBIX53660
2.72%
Bio-Techne CorpTECH122004
2.68%
Halozyme Therapeutics IncHALO99880
2.58%
ACADIA Pharmaceuticals IncACAD285787
2.53%
BioMarin Pharmaceutical IncBMRN112225
2.52%
Ionis Pharmaceuticals IncIONS82240
2.50%
Repligen CorpRGEN52183
2.47%
Veracyte IncVCYT196903
2.47%
Vericel CorpVCEL183726
2.44%
Theravance Biopharma IncTBPH368704
2.44%
CareDx IncCDNA365065
2.38%
QIAGEN NVQGEN144898.3786
2.20%
Collegium Pharmaceutical IncCOLL155578
1.30%
MannKind CorpMNKD1268504
0.10%
Invesco Government & Agency PortfolioAGPXX260375.68
0.00%
CASH & EQUIVALENTSUSD5728